Biocon Biologics Ireland Limited
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 2
- Period
- 8 July 2026 – 23 September 2026
Its main clients
- Amgros I/S · 1 contract
- Region Skåne, Koncernstab inköp och ekonomistyrning · 1 contract
Where and what
Supplies · 2
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 31 August 2028 re-tender around March 2028 |
Läkemedel 2026 del 2
Region Skåne, Koncernstab inköp och ekonomistyrning framework agreement |
Biocon Biologics Ireland Limited Celltrion Sweden AB Grunenthal Sweden AB Øresund Pharma ApS 9 bids received |
– |
| 31 March 2029 re-tender around October 2028 |
Amgros 2027 1.1052.b
Amgros I/S framework agreement |
Biocon Biologics Ireland Limited Orion Pharma A/S Pfizer ApS Samsung Bioepis NL B.V. Accord Healthcare AB Roche Pharmaceuticals A/S Orifarm A/S Abacus Medicine A/S 2care4 ApS 5 bids received |
– |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 23/09/2026 | Amgros 2027 1.1052.b | Amgros I/S | – |
| 08/07/2026 | Läkemedel 2026 del 2 | Region Skåne, Koncernstab inköp och ekonomistyrning | – |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.